Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis.
about
Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional studyLong term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
P2860
Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Entecavir for Patients with He ...... sis in China: a meta-analysis.
@en
Entecavir for Patients with He ...... sis in China: a meta-analysis.
@nl
type
label
Entecavir for Patients with He ...... sis in China: a meta-analysis.
@en
Entecavir for Patients with He ...... sis in China: a meta-analysis.
@nl
prefLabel
Entecavir for Patients with He ...... sis in China: a meta-analysis.
@en
Entecavir for Patients with He ...... sis in China: a meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
Entecavir for Patients with He ...... sis in China: a meta-analysis.
@en
P2093
P2860
P2888
P356
10.1038/SREP32722
P407
P577
2016-09-07T00:00:00Z